This session is from the HOPA 2017 Annual Conference
Speaker: Vivian Park, PharmD MBA BCOP
Learning Objectives:
1. Describe the mechanisms of action of hematology/oncology drugs approved by the U.S. Food and Drug Administration (FDA) in 2016.
2. &...
This session is from the HOPA 2017 Annual Conference
Speaker: Vivian Park, PharmD MBA BCOP
Learning Objectives:
1. Describe the mechanisms of action of hematology/oncology drugs approved by the U.S. Food and Drug Administration (FDA) in 2016.
2. Summarize key data supporting approval and the purported clinical benefits of these drugs.
3. Identify common adverse events and appropriate prevention or management of such events.